CAS: 125700-71-2; O-(2-Oxo-1(2H)Pyridyl)-N,N,N',N'-Tetramethyluronium Tetrafluoroborate

该化合物是一种化学化合物,主要用作有机合成的试剂,特别是在混合反应领域.该物质的特点是其独特的结构,包括一个环和四甲基,有助于其反应性和溶性.它通常被用作反应性电极的来源,有利于形成碳-碳和碳-硝基联结.四氟乙酸酯在极地溶剂中增强稳定性和溶性,使之适合各种合成用途.此外,该化合物因其能够激活氨化物结合的碳酸箱酸而闻名,这对于聚氨化物合成和其他有机变异体至关重要.在处理该化合物时,应注意安全防范措施,因为如果浸入或吸入,可能会对健康造成危害.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    1,1,3,3-四甲基脲 反应生成N-甲基甲酰胺
    参考文献:Knorr,Reinhard;Trzeciak,Arnold;Bannwarth,Willi;Gillessen,Dieter,Tetrahedron Lett.,30,(1989) N5,C. 1927-1930
    标题:Knorr,Reinhard;Trzeciak,Arnold;Bannwarth,Willi;Gillessen,Dieter,Tetrahedron Lett.,30,(1989) N5,C. 1927-1930

    海关参考信息

    专利信息


    专利号:US-7288661-B2
    优先权日:2003-12-10
    标 题 :Process for the synthesis of (2S,3aS,7aS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid compounds and application in the synthesis of perindopril
    发明人:DUBUFFET THIERRY; LECOUVE JEAN-PIERRE
    权利人:SERVIER LAB
    摘要:Process for the synthesis of compounds of formula (I): n nwherein R represents a hydrogen atom or a protecting group for the amino function.n n Application in the synthesis of perindopril and pharmaceutically acceptable salts thereof.

    专利号:US-6248891-B1
    优先权日:1997-05-23
    标题:Synthesis of acridine derivative multidrug-resistant inhibitors
    发明人:SHARP MATTHEW JUDE; MADER CATHERINE J; STRACHAN CALUM
    权利人:GLAXO WELLCOME INC
    摘要:Synthesis of the MDRI of formula (I) from intermediates of acridone acid of formula (II) and aminophenethyl isoquinoline of formula (III), via steps including coupling and conversion to yield the MDRI of formula (I).

    专利号:US-7973175-B2
    优先权日:2005-09-28
    标 题 :Synthesis of renin inhibitors involving a cycloaddition reaction
    发明人:MICKEL STUART J; MARTERER WOLFGANG
    权利人:NOVARTIS AG
    摘要:The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a process for the manufacture of a compound of the formula III, n nwherein R, R 1 , and R′ are as defined in the specification, or a salt thereof, and a compound of formula IVn n nwherein R, R 1 , R 2 and R′ are as defined in the specification, and processes of manufacturing these.

    专利号:US-11708341-B2
    优先权日:2016-08-05
    标题:Synthesis of (S)-2-amino-4-methyl-((R)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
    发明人:Beaver Matthew; CUI SHENG; SHI XIANGQING
    权利人:AMGEN INC
    摘要:The present invention provides new methods for preparing compound 5, and pharmaceutically acceptable salts thereof, of structure n nCompound 5, or a pharmaceutically acceptable salt thereof, is an important intermediate in the synthesis of carfilzomib. The invention further provides methods of making a useful manganese catalyst that may be used in the epoxidation step of the present invention.

    专利号:US-7279583-B2
    优先权日:2003-12-10
    标题:Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
    发明人:DUBUFFET THIERRY; LECOUVE JEAN-PIERRE
    权利人:SERVIER LAB
    摘要:Process for the industrial synthesis of perindopril of formula (I): n nand pharmaceutically acceptable salts thereof.

    专利号:US-2024218014-A1
    优先权日:2022-11-21
    标 题:Synthesis of a cyclic peptide
    发明人:BAUR PIUS BRUNO; CLEATOR EDWARD; DENIAU GILDAS; EISELE FRANK; FLÖGEL OLIVER; HUSTE ANJA; KEHL MARCEL ROMAN; LÖWENECK MARKUS; SILVA ROLANDO RAVELO; VORBERG RAFFAEL
    权利人:JANSSEN PHARMACEUTICA NV
    摘要:Processes for performing peptide synthesis, particularly for cyclic peptide synthesis are generally described. Reaction intermediates of the peptide synthesis are also described.
    上海西加生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sigachem.com
    企业联系电话:18901978308👤
    📞上海西加生物科技有限公司 ⚠️参考联系方式
    联系人:龚经理
    电话:18901978308
    手机:13764598896

    邮箱:grace8018@163.com
    通信地址: 上海市崇明区新河镇新申路921弄2号W区175室
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市崇明区新河镇新申路921弄2号W区175室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    苏州昊帆生物股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.highfine.com
    电话: 0512-68071238👤
    📞苏州昊帆生物股份有限公司 ⚠️参考联系方式

    销售电话:0512-68071238
    邮箱:sales@highfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: R T Pon, Et Al. Rapid Esterification Of Nucleosides To Solid-Phase Supports For Oligonucleotide Synthesis Using Uronium And Phosphonium Coupling Reagents. Bioconjug Chem. 1999 Nov-Dec;10(6):1051-7.
    [参考文献]: Tomohisa Sawada, Et Al. Structural Mimicry Of The α-Helix In Aqueous Solution With An Isoatomic α/β/γ-Peptide Backbone. J Am Chem Soc. 2011 May 18;133(19):7336-9.

    合成参考文献


    参考文献:10.1007/978-981-10-0858-0_1
    摘要:Janairo JIB. Introduction to Peptide Chemistry and Materials Characterization. 2016. In: SpringerBriefs in Materials.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知